FDA Clears QIAGEN Bloodstream Infection Panel
QIAGEN has received FDA clearance for its QIAstat-Dx BCID GPF Plus AMR Panel, enabling detection of 20 pathogens and 10 antimicrobial resistance markers from positive blood cultures in about one hour.
QIAGEN has received FDA clearance for its QIAstat-Dx BCID GPF Plus AMR Panel, enabling detection of 20 pathogens and 10 antimicrobial resistance markers from positive blood cultures in about one hour.
GenomOncology and PacBio have introduced an integrated workflow for somatic whole-genome sequencing in oncology, combining PacBio’s HiFi WGS analysis with GenomOncology’s reporting platform for standardized clinical lab reporting.
Labcorp has announced the upcoming launch of the Marker by Labcorp Genetic Health Panel, which will analyze 163 genes linked to over 100 medically actionable conditions, with results supported by licensed genetic counselors.
Myriad Genetics has launched the FirstGene Multiple Prenatal Screen, a test that combines four prenatal genetic screens from a single blood draw as early as eight weeks gestation, according to the company.
Read MoreSeegene has launched the Global Million Clinical Study to collect real-world data on the clinical utility of syndromic PCR testing for infectious diseases, aiming to inform future global diagnostic standards.
Read MoreThe deal adds a blood-based test for viral-mediated cancers to the company’s portfolio of transplant and cell therapy services.
Read MoreBehavioral Diagnostics and Versiti Clinical Trial Solutions have partnered to provide epigenetic assays for objective smoking and alcohol exposure screening in clinical trials, aiming to improve participant risk assessment and data reliability.
Read MoreQIAGEN’s FDA-cleared QIAstat-Dx panel detects Cyclospora cayetanensis, addressing a surge of over 1,600 confirmed US cases since May 2026.
Read MoreNabsys and Leiden University Medical Center are collaborating to evaluate an electronic genome mapping assay for improved detection of FSHD-associated repeat contractions, aiming to address current diagnostic limitations.
Read MoreThe fully automated, high-throughput assay for Hepatitis D virus RNA is available on cobas 5800/6800/8800 systems in CE mark-accepting countries.
Read MoreBio-Rad has launched Vericheck ddPCR kits for quality control in cell and gene therapy manufacturing, offering validated workflows for mycoplasma detection, capsid analysis, and residual DNA quantification.
Read MoreThe test utilizes genomic sequencing and AI to identify biological signals associated with early-stage disease.
Read MoreThe transaction includes subsidiaries in the United States, Sweden, and Australia to expand transplantation diagnostic offerings.
Read MoreResearch suggests new sequencing technologies can help labs move from tissue-level averages to cell-specific testing for precision exercise medicine.
Read MoreHerAnova Lifesciences presented validation data for HerResolve, a blood-based endometriosis test, showing 94.4% accuracy and detection of cases missed by imaging.
Read MoreRoche has launched AXELIOS 1, a single-molecule sequencing platform that uses sequencing by expansion technology to deliver same-day whole-genome results.
Read MoreThe agreement combines extraction and PCR technologies to create an end-to-end workflow for DNA and RNA analysis.
Read MoreThe new technologies address library normalization and amplification accuracy for high-throughput and oncology sequencing.
Read More